Randomized double-blind comparison of the safety and efficacy of novel once daily and conventional twice daily formulation of ciprofloxacin in uncomplicated urinary tract infection

被引：2
|
作者：
Berner, B
Cramer, M
Park, M
Chiang, YK
Louie-Helm, J
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)37357-9
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of once-daily carvedilol in patients with atrial fibrillation: A randomized, double-blind, placebo-controlled trial
    Choi, Jong-Il
    Park, Yae Min
    Oh, Yong-Seog
    Kim, Jin-Bae
    Han, Seongwook
    Park, Jong-Sung
    On, Young Keun
    Choi, Kee-Joon
    Hwang, Gyo-Seung
    Lee, Moon-Hyoung
    Shin, Dong-Gu
    Kim, Nam-Ho
    Kim, Dae-Kyeong
    Namgung, June
    Kim, Dae-Hyeok
    Park, Hyung-Wook
    Park, Hwan-Cheol
    Choi, Eue-Keun
    Rhee, Kyoung Suk
    Shin, Seung Yong
    Kim, Young-Hoon
    HEART RHYTHM, 2024, 21 (10) : 2051 - 2052
  • [42] Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections
    Naber, KG
    Allin, DM
    Clarysse, L
    Haworth, DA
    James, IGV
    Raini, C
    Schneider, H
    Wall, A
    Weitz, P
    Hopkins, G
    Ankel-Fuchs, D
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 23 (06) : 596 - 605
  • [43] Efficacy of once-daily extended-release ciprofloxacin for treatment of uncomplicated urinary tract infections due to Staphylococcus saprophyticus.
    Oberoi, M
    Haverstock, D
    Cyrus, P
    Kowalsky, S
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (02) : S399 - S399
  • [44] Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease
    Jones, Roy W.
    Bayer, Antony
    Inglis, Fraser
    Barker, Andrew
    Phul, Ravinder
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 22 (03) : 258 - 262
  • [45] THE ANTIANGINAL EFFICACY AND TOLERABILITY OF CONTROLLED-RELEASE METOPROLOL ONCE DAILY - A COMPARISON WITH CONVENTIONAL METOPROLOL TABLETS TWICE DAILY
    EGSTRUP, K
    GUNDERSEN, T
    HARKONEN, R
    KARLSSON, E
    LUNDGREN, B
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 33 : S45 - S45
  • [46] DOUBLE-BLIND CROSSOVER TRIAL OF ONCE VERSUS TWICE-DAILY DOSE OF ATENOLOL IN HYPERTENSION
    MAXWELL, MH
    WAKS, AU
    GROSS, C
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1983, 34 (04): : 613 - 619
  • [47] Combination amoxycillin and metronidazole with famotidine in the eradication of Helicobacter pylori - a randomized, double-blind comparison of a three times daily and twice daily regimen
    Goh, KL
    Parasakthi, N
    Chuah, SY
    Toetsch, M
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (11) : 1091 - 1095
  • [48] Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial
    Porst, Hartmut
    Kim, Edward D.
    Casabe, Adolfo R.
    Mirone, Vincenzo
    Secrest, Roberta J.
    Xu, Lei
    Sundin, David P.
    Viktrup, Lars
    EUROPEAN UROLOGY, 2011, 60 (05) : 1105 - 1113
  • [49] RANDOMIZED, DOUBLE-BLIND COMPARISON OF CEFEPIME AND CEFTAZIDIME THERAPY FOR URINARY-TRACT INFECTION
    PREHEIM, LC
    CHILDS, SJ
    RAJFER, J
    BITTNER, MJ
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (08): : 729 - 737
  • [50] EFFICACY AND SAFETY OF ONCE-DAILY CEFTIBUTEN VS, TWICE-DAILY CIPROFLOXACIN IN THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC-BRONCHITIS
    BENSCH, GW
    KLAUSTERMEYER, WB
    MCCARTHY, J
    SCHWORER, PB
    TAGLIETTI, MA
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1995, 4 : S80 - S87
12345